BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26576645)

  • 1. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.
    Mileo AM; Mattarocci S; Matarrese P; Anticoli S; Abbruzzese C; Catone S; Sacco R; Paggi MG; Ruggieri A
    J Exp Clin Cancer Res; 2015 Nov; 34():140. PubMed ID: 26576645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of pRb2/p130 interaction with cyclins.
    Claudio PP; De Luca A; Howard CM; Baldi A; Firpo EJ; Koff A; Paggi MG; Giordano A
    Cancer Res; 1996 May; 56(9):2003-8. PubMed ID: 8616840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
    Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
    Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma.
    Huynh H
    Carcinogenesis; 2004 Aug; 25(8):1485-94. PubMed ID: 15059924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107.
    Claudio PP; Howard CM; Baldi A; De Luca A; Fu Y; Condorelli G; Sun Y; Colburn N; Calabretta B; Giordano A
    Cancer Res; 1994 Nov; 54(21):5556-60. PubMed ID: 7923196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
    Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
    J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
    Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy.
    Giordano A; Rossi A; Romano G; Bagella L
    J Cell Physiol; 2007 Nov; 213(2):403-6. PubMed ID: 17708530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the retinoblastoma family of tumor suppressors during murine embryonic orofacial development.
    Leezer JL; Hackmiller RC; Greene RM; Pisano MM
    Orthod Craniofac Res; 2003 Feb; 6(1):32-47. PubMed ID: 12627794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent loss of pRb2/p130 in human ovarian carcinoma.
    D'Andrilli G; Masciullo V; Bagella L; Tonini T; Minimo C; Zannoni GF; Giuntoli RL; Carlson JA; Soprano DR; Soprano KJ; Scambia G; Giordano A
    Clin Cancer Res; 2004 May; 10(9):3098-103. PubMed ID: 15131049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoblastoma-related protein pRb2/p130 and suppression of tumor growth in vivo.
    Howard CM; Claudio PP; Gallia GL; Gordon J; Giordano GG; Hauck WW; Khalili K; Giordano A
    J Natl Cancer Inst; 1998 Oct; 90(19):1451-60. PubMed ID: 9776410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.
    Leoncini L; Bellan C; Cossu A; Claudio PP; Lazzi S; Cinti C; Cevenini G; Megha T; Laurini L; Luzi P; Orcioni GF; Piccioli M; Pileri S; Giardino C; Tosi P; Giordano A
    Clin Cancer Res; 1999 Dec; 5(12):4065-72. PubMed ID: 10632341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies.
    Minimo C; Bibbo M; Claudio PP; De Luca A; Giordano A
    Pathol Res Pract; 1999; 195(2):67-70. PubMed ID: 10093823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma family proteins induce differentiation and regulate B-myb expression in neuroblastoma cells.
    Raschellà G; Tanno B; Bonetto F; Negroni A; Amendola R; Paggi MG
    Med Pediatr Oncol; 2001 Jan; 36(1):104-7. PubMed ID: 11464857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of pRB2/p130 in cellular growth regulation.
    Stiegler P; Giordano A
    Anal Quant Cytol Histol; 1999 Aug; 21(4):363-6. PubMed ID: 10560516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway.
    Sun A; Bagella L; Tutton S; Romano G; Giordano A
    J Cell Biochem; 2007 Dec; 102(6):1400-4. PubMed ID: 17979151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.
    Russo G; Claudio PP; Fu Y; Stiegler P; Yu Z; Macaluso M; Giordano A
    Oncogene; 2003 Oct; 22(44):6959-69. PubMed ID: 14534545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation.
    Raschellà G; Tanno B; Bonetto F; Negroni A; Claudio PP; Baldi A; Amendola R; Calabretta B; Giordano A; Paggi MG
    Cell Death Differ; 1998 May; 5(5):401-7. PubMed ID: 10200489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
    Stiegler P; De Luca A; Bagella L; Giordano A
    Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.